MicroRNAs play an essential role in the development of cardiac hypertrophy
- PMID: 17234972
- DOI: 10.1161/01.RES.0000257913.42552.23
MicroRNAs play an essential role in the development of cardiac hypertrophy
Abstract
MicroRNAs are naturally existing, small, noncoding RNA molecules that downregulate posttranscriptional gene expression. Their expression pattern and function in the heart remain unknown. Here we report an array of microRNAs that are differentially and temporally regulated during cardiac hypertrophy. Significantly, the muscle-specific microRNA-1 (miR-1) was singularly downregulated as early as day 1 (0.56+/-0.036), persisting through day 7 (0.29+/-0.14), after aortic constriction-induced hypertrophy in a mouse model. Overexpression experiments showed that miR-1 inhibited its in silico-predicted, growth-related targets, including Ras GTPase-activating protein (RasGAP), cyclin-dependent kinase 9 (Cdk9), fibronectin, and Ras homolog enriched in brain (Rheb), in addition to protein synthesis and cell size. Thus, we propose that microRNAs play an essential regulatory role in the development of cardiac hypertrophy, wherein downregulation of miR-1 is necessary for the relief of growth-related target genes from its repressive influence and induction of hypertrophy.
Similar articles
-
lncRNA UCA1 Is a Novel Regulator in Cardiomyocyte Hypertrophy through Targeting the miR-184/HOXA9 Axis.Cardiorenal Med. 2018;8(2):130-139. doi: 10.1159/000487204. Epub 2018 Mar 20. Cardiorenal Med. 2018. PMID: 29616999 Free PMC article.
-
Myocardial Hypertrophic Preconditioning Attenuates Cardiomyocyte Hypertrophy and Slows Progression to Heart Failure Through Upregulation of S100A8/A9.Circulation. 2015 Apr 28;131(17):1506-17; discussion 1517. doi: 10.1161/CIRCULATIONAHA.114.013789. Epub 2015 Mar 27. Circulation. 2015. PMID: 25820336 Free PMC article.
-
Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.J Cell Mol Med. 2015 Mar;19(3):608-19. doi: 10.1111/jcmm.12445. Epub 2015 Jan 13. J Cell Mol Med. 2015. PMID: 25583328 Free PMC article.
-
MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors.Circulation. 2013 May 28;127(21):2097-106. doi: 10.1161/CIRCULATIONAHA.112.000882. Epub 2013 Apr 26. Circulation. 2013. PMID: 23625957
-
Everything you wanted to know about small RNA but were afraid to ask.Lab Invest. 2008 Jun;88(6):569-78. doi: 10.1038/labinvest.2008.32. Epub 2008 Apr 21. Lab Invest. 2008. PMID: 18427554 Review.
Cited by
-
miR-29a activates expression of α-cardiac myosin heavy chain via β1 thyroid hormone receptor in neonatal rats.Arch Med Sci. 2020 Jan 8;20(2):641-654. doi: 10.5114/aoms.2019.91495. eCollection 2024. Arch Med Sci. 2020. PMID: 38757019 Free PMC article.
-
Discovery of circulating miRNAs as biomarkers of chronic Chagas heart disease via a small RNA-Seq approach.Sci Rep. 2024 Jan 12;14(1):1187. doi: 10.1038/s41598-024-51487-9. Sci Rep. 2024. PMID: 38216639 Free PMC article.
-
Nanocurcumin Reduces High Glucose and Particulate Matter-Induced Endothelial Inflammation: Mitochondrial Function and Involvement of miR-221/222.Int J Nanomedicine. 2023 Dec 6;18:7379-7402. doi: 10.2147/IJN.S433658. eCollection 2023. Int J Nanomedicine. 2023. PMID: 38084125 Free PMC article.
-
Non-coding RNAs in disease: from mechanisms to therapeutics.Nat Rev Genet. 2024 Mar;25(3):211-232. doi: 10.1038/s41576-023-00662-1. Epub 2023 Nov 15. Nat Rev Genet. 2024. PMID: 37968332 Review.
-
Reducing branched-chain amino acids improves cardiac stress response in mice by decreasing histone H3K23 propionylation.J Clin Invest. 2023 Nov 15;133(22):e169399. doi: 10.1172/JCI169399. J Clin Invest. 2023. PMID: 37669116 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
